Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye.
Tekinalp A, Gedük A, Akdeniz A, Terzi Demirsoy E, Gürsoy V, Aslaner Ak M, Bağcı M, Seçilmiş S, Keklik Karadağ F, Oruç Uysal A, Doğan A, Demircioğlu S, Erol HA, Aslan C, Özkalemkaş F, Ertop Ş, Dağlı M, Dal MS, Saydam G, Merter M, Ural C, Çeneli Ö. Tekinalp A, et al. Among authors: erol ha. Turk J Haematol. 2023 Dec 5;40(4):242-250. doi: 10.4274/tjh.galenos.2023.2023.0029. Epub 2023 Nov 14. Turk J Haematol. 2023. PMID: 37961952 Free PMC article.
Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.
Geduk A, Oztas B, Eryılmaz BH, Demirsoy ET, Menguc MU, Unal S, Mersin S, Polat MG, Aygun K, Yenihayat EM, Albayrak H, Erol HA, Balcı S, Mehtap O, Tarkun P, Hacihanefioglu A. Geduk A, et al. Among authors: erol ha. Indian J Hematol Blood Transfus. 2023 Apr;39(2):220-227. doi: 10.1007/s12288-022-01574-6. Epub 2022 Oct 17. Indian J Hematol Blood Transfus. 2023. PMID: 37006982 Free PMC article.
Correction to: Efects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.
Geduk A, Oztas B, Eryılmaz BH, Demirsoy ET, Menguc MU, Unal S, Mersin S, Polat MG, Aygun K, Yenihayat EM, Albayrak H, Erol HA, Balcı S, Mehtap O, Tarkun P, Hacihanefioglu A. Geduk A, et al. Among authors: erol ha. Indian J Hematol Blood Transfus. 2023 Jul;39(3):518. doi: 10.1007/s12288-023-01626-5. Epub 2023 Jan 18. Indian J Hematol Blood Transfus. 2023. PMID: 37304480 Free article.
Do Alarmins Have a Role in Multiple Myeloma?
Gedük A, Polat MG, Terzi Demirsoy E, Öztaş B, Eryılmaz BH, Yenihayat EM, Albayrak H, Erol HA, Mehtap Ö, Tarkun P, Hacıhanefioğlu A. Gedük A, et al. Among authors: erol ha. Turk J Haematol. 2024 May 30;41(2):83-90. doi: 10.4274/tjh.galenos.2024.2023.0469. Epub 2024 Mar 1. Turk J Haematol. 2024. PMID: 38426298 Free article.
Measuring the Impact of a Formalized Surgical Patient Signout System.
Mahoney RC, Goto D, Erol HA, Sheu J, Chen YA, Morrison B, Cryer C, Murayama KM. Mahoney RC, et al. Among authors: erol ha. J Surg Educ. 2023 Aug;80(8):1150-1157. doi: 10.1016/j.jsurg.2023.06.003. Epub 2023 Jun 28. J Surg Educ. 2023. PMID: 37391306
Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019.
Aydin Guclu O, Goktas SS, Gorek Dilektasli A, Acet Ozturk NA, Demirdogen E, Coskun F, Ediger D, Ursavas A, Uzaslan E, Erol HA, Karacay ND, Kaya Sel U, Karadag M. Aydin Guclu O, et al. Among authors: erol ha. Intern Med J. 2022 Sep;52(9):1495-1504. doi: 10.1111/imj.15728. Epub 2022 Aug 19. Intern Med J. 2022. PMID: 35257465 Free PMC article.